Question 1

What is Sergey Paushkin?

Accepted Answer

Sergey Paushkin is a Person.

Question 2

How often does Sergey Paushkin appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 15 articles.

Question 3

When was Sergey Paushkin first tracked by Ergen?

Accepted Answer

First tracked on Jun 30, 2026.

Question 4

When was Sergey Paushkin last mentioned in news?

Accepted Answer

Last active on Jul 14, 2026.

Question 5

What is Sergey Paushkin's current news sentiment?

Accepted Answer

Aggregate sentiment score: 38 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Sergey Paushkin in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Sergey Paushkin?

Accepted Answer

Skyhawk SKY-0515 Huntington's Trial Results (Jun 30, 2026, 7 articles).

Question 8

How did the "Skyhawk SKY-0515 Huntington's Trial Results" event impact Sergey Paushkin?

Accepted Answer

Sergey Paushkin, Head of R&D at Skyhawk Therapeutics, expressed satisfaction with the positive subcomponent data and the potential of SKY-0515 to offer a much-needed therapy for Huntington s disease patients.

Question 9

How did the "Skyhawk expands FALCON-HD trial to US, UK, Canada" event impact Sergey Paushkin?

Accepted Answer

Sergey Paushkin is the head of R&D at Skyhawk Therapeutics and is quoted in the announcement, representing the company's scientific leadership.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.